Nutra Pharma NPHC Stock
Nutra Pharma Price Chart
Nutra Pharma NPHC Financial and Trading Overview
| Nutra Pharma stock price | 0.0002 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0002 USD |
| Bid | 0.0002 USD x 110931200 |
| Ask | 0.0009 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.005 USD |
| Volume | 688 USD |
| Avg. Volume | 608.59K USD |
| Market Cap | 1.43M USD |
| Beta (5Y Monthly) | 57.515 |
| PE Ratio (TTM) | |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NPHC Valuation Measures
| Enterprise Value | 13.09M USD |
| Trailing P/E | |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 2.25 |
| Price/Sales (ttm) | 4.431524 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 40.525 |
| Enterprise Value/EBITDA | -8.843 |
Trading Information
Nutra Pharma Stock Price History
| Beta (5Y Monthly) | 57.515 |
| 52-Week Change | 100.00% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.005 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000222 USD |
| 200-Day Moving Average | 0.0002325 USD |
NPHC Share Statistics
| Avg. Volume (3 month) | 608.59K USD |
| Avg. Daily Volume (10-Days) | 584.91K USD |
| Shares Outstanding | 7.16B |
| Float | 7.09B |
| Short Ratio | N/A |
| % Held by Insiders | 1.01% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -786.59% |
| Gross Margin | 48.42% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -133.98% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 323.13K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -56.29% |
| Gross Profit (ttm) | 156.47K USD |
| EBITDA | -1480763 USD |
| Net Income Avi to Common (ttm) | -1102144 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.44K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 11.69M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.028 |
| Book Value Per Share (mrq) | -0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1086749 USD |
| Levered Free Cash Flow (ttm) | -1090852 USD |
Profile of Nutra Pharma
| Country | United States |
| State | FL |
| City | Boca Raton |
| Address | 6400 Park of Commerce Blvd |
| ZIP | 33487 |
| Phone | 954 509 0911 |
| Website | https://www.nutrapharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin/Nyloxin Extra Strength, an over-the-counter (OTC) pain reliever; Pet Pain-Away, a homeopathic, nonnarcotic, nonaddictive, overthecounter pain reliever to treat moderate to severe chronic pain in companion animals; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxury Feet, an OTC pain reliever for foot pain from high heels and stilettos. It is also involved in developing RPI-78M to treat neurological and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, and general anti -viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Boca Raton, Florida.
Q&A For Nutra Pharma Stock
What is a current NPHC stock price?
Nutra Pharma NPHC stock price today per share is 0.0002 USD.
How to purchase Nutra Pharma stock?
You can buy NPHC shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nutra Pharma?
The stock symbol or ticker of Nutra Pharma is NPHC.
Which industry does the Nutra Pharma company belong to?
The Nutra Pharma industry is Drug Manufacturers - Specialty & Generic.
How many shares does Nutra Pharma have in circulation?
The max supply of Nutra Pharma shares is 7.16B.
What is Nutra Pharma Price to Earnings Ratio (PE Ratio)?
Nutra Pharma PE Ratio is now.
What was Nutra Pharma earnings per share over the trailing 12 months (TTM)?
Nutra Pharma EPS is 0 USD over the trailing 12 months.
Which sector does the Nutra Pharma company belong to?
The Nutra Pharma sector is Healthcare.